Biotechnology News and Research

RSS

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

Antiverse Ltd (Antiverse) and GlobalBio, Inc. (GlobalBio) today announced they will be extending their collaboration to advance immune checkpoint inhibitors in cancer therapy.

From Antiverse 16 Oct 2023

£800,000 grant to boost the development of bacteriophages to combat disease

Pioneering work to develop effective and safe bacteriophages to combat disease has received an £800,000 boost.

13 Oct 2023

Nongenetic mechanisms play a role in lung cancer treatment resistance

In a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology, a team of researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States, and other institutions found that nongenetic mechanisms are important in lung cancer patients who develop a resistance to one cancer therapy.

13 Oct 2023

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

Moderna's updated mRNA-1273.815 COVID-19 vaccine shows promising results in reducing symptomatic cases, hospitalizations, and deaths in high-risk and older adults in Germany. The study finds the vaccine to be more cost-effective and clinically beneficial than both no vaccination and Pfizer's XBB.1.5 BNT162b2 vaccine.

12 Oct 2023

Ensuring raw material quality in drug production and manufacturing

In this interview, Thermo Fisher Scientific discusses how to ensure the high quality of raw material in the drug production and manufacturing pipeline.

From Thermo Fisher Scientific – Materials & Structural Analysis 12 Oct 2023

New blood test could detect ovarian cancer early, improve treatment

High-grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer. It is also the most lethal form, in part because clinicians do not have effective ways to screen women for it during the cancer's early stages, when it's easiest to treat.

10 Oct 2023

New drug shows promise for epilepsy patients with resistant seizures

In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows.

9 Oct 2023

Targeting Microbiota 2023 captures the essence of microbiota research and future implications

Targeting Microbiota 2023 will be a ground-breaking experience that will introduce you to the latest advancements in the microbiota field.

9 Oct 2023

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

Sino Biological, Inc. is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the world-renowned Texas Medical Center.

From Sino Biological Inc. 9 Oct 2023

Neonatal ICU mystery: Unraveling the secrets of the prevalent Staphylococcus strain

Researchers delve into the genomes of Staphylococcus capitis isolates prevalent in neonates, revealing transmission patterns and survival tactics of the NRCS-A strain in neonatal ICUs.

8 Oct 2023

Researchers develop innovative treatment option for therapy-resistant epilepsy

Neuroscientist Professor Sonja Bröer from Freie Universität Berlin is involved in the development of an innovative treatment option for therapy-resistant epilepsy.

6 Oct 2023

Altering certain molecular interactions could yield new strategies for treating prostate cancer

Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered that altering certain molecular interactions could yield new strategies for treating prostate cancer and related diseases.

6 Oct 2023

Study reveals unexpected variation in genetic code of protist

Scientists testing a new method of sequencing single cells have unexpectedly changed our understanding of the rules of genetics.

6 Oct 2023

New computational method improves analysis of single-cell transcriptomic data

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed a new open-source computational method, dubbed Spectra, which improves the analysis of single-cell transcriptomic data.

5 Oct 2023

New zebrafish xenograft platform could help screen for glioblastoma treatments

Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study by the Gerhardt and De Smet labs published in EMBO Molecular Medicine.

4 Oct 2023

Identification of Alzheimer's disease-associated micro-RNA biomarkers through network-based analysis

Micro-ribonucleic acids (miRNAs) linked to cognition and Alzheimer's disease (AD).

3 Oct 2023

Could seaweeds be the superfood and medicine of the future?

Researchers consolidate the diverse nutritional and medicinal benefits of seaweeds, touting their potential in food, nutraceuticals, and pharmaceuticals. The study also highlights challenges and opportunities in industrial applications, calling for more research to optimize extraction and refinement processes.

2 Oct 2023

STEMCELL Technologies partners with Science World to empower girls pursuing science-related careers

STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce it will be the presenting partner of the Girls and STEAM Summit at Science World in Vancouver.

From STEMCELL Technologies Inc. 29 Sep 2023

Sushi and other raw seafood can spread antibiotic-resistant bacteria, study warns

Bacteria in raw seafood can make you sick. Seafood can also spread bacteria that are resistant to antibiotics.

28 Sep 2023

Newly identified stem cell variants drive inflammation in cystic fibrosis patients

Two nationally recognized experts in cloning and stem cell science from the University of Houston, Wa Xian and Frank McKeon, are reporting that five lung stem cell variants dominate the lungs of patients with advanced cystic fibrosis (CF), and that these variants drive key aspects of CF pathology including inflammation, fibrosis and mucin secretion.

28 Sep 2023

Biotechnology News and Research

Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

£800,000 grant to boost the development of bacteriophages to combat disease

Nongenetic mechanisms play a role in lung cancer treatment resistance

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

Ensuring raw material quality in drug production and manufacturing

New blood test could detect ovarian cancer early, improve treatment

New drug shows promise for epilepsy patients with resistant seizures

Targeting Microbiota 2023 captures the essence of microbiota research and future implications

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

Neonatal ICU mystery: Unraveling the secrets of the prevalent Staphylococcus strain

Researchers develop innovative treatment option for therapy-resistant epilepsy

Altering certain molecular interactions could yield new strategies for treating prostate cancer

Study reveals unexpected variation in genetic code of protist

New computational method improves analysis of single-cell transcriptomic data

New zebrafish xenograft platform could help screen for glioblastoma treatments

Identification of Alzheimer's disease-associated micro-RNA biomarkers through network-based analysis

Could seaweeds be the superfood and medicine of the future?

STEMCELL Technologies partners with Science World to empower girls pursuing science-related careers

Sushi and other raw seafood can spread antibiotic-resistant bacteria, study warns

Newly identified stem cell variants drive inflammation in cystic fibrosis patients

Biotechnology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News